CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Boai NKY Medical Holdings Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Boai NKY Medical Holdings Ltd
No.1888
(East Section) Wenhua Road, Boai County
Phone: +86 3918610680p:+86 3918610680 JIAOZUO, HEN  454450  China Ticker: 300109300109
Business Summary
Boai NKY Medical Holdings Ltd., formerly Boai NKY Pharmaceuticals Ltd., is a China-based company principally engaged in the research, development, production and distribution of polyvinyl pyrrolidone (PVP) series products and polyvinyl methyl ether and maleic anhydride (PVME/MA) series products. The Company’s main products include GBL, 2- pyrrolidone, N-vinylpyrrolidone (NVP) monomer, PVP-K series (PVPK), polyvinylpolypyrrolidone (PPVP), PVP- Iodine (PVP-I), related pharmaceutical intermediates and others. The Company's products are mainly used in daily chemical, medicine, liquor and beverage, pigments and coatings, textile, paper making, oil extraction, sensitive material, electronic and other industries. The Company distributes its products in domestic market and to overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2869 Industrial organic chemicals, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager JunzhengZhang 47 3/23/2023 4/26/2009
Vice Chairman of the Board HongboYang 49 9/3/2019
Vice Chairman of the Board WeiZhao 58 9/3/2019 9/3/2019
11 additional Officers and Directors records available in full report.

Business Names
Business Name
300109
Boai NKY Pharmaceuticals Ltd

General Information
Number of Employees: 1,165 (As of 12/31/2023)
Outstanding Shares: 484,700,005 (As of 9/30/2024)
Shareholders: 19,609
Stock Exchange: SHE
Fax Number: +86 3918610681


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024